Aberrant expression and reverse signalling of CD70 on malignant B cells

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 491-503

  Lens, Susanne M A ^a,b,c   Drillenburg, Paul ^b   Den Drijver, Bianca F A ^a   Van Schijndel, Gijs ^a   Pals, Steven T ^b   Van Lier, René A W ^a,b   Van Oers, Marinus H J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

B lymphocytes; CD27; CD70; Human; Malignant

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; HUMAN; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, CD70; B-LYMPHOCYTES; CELL COMMUNICATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032871425     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01573.x     Document Type: Article

References (64)

1. Agathanggelou, A., Niedobitek, G., Chen, R., Nicholls, J., Yin, W. & Young, L.S. (1995) Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma: evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. American Journal of Pathology, 147, 1152-1160.
2. Agematsu, K., Kobata, T., Sugita, K., Freeman, G.J., Beckmann, M.P., Schlossman, S.F. & Morimoto, C. (1994) Role of CD27 in T cell immune response: analysis by recombinant soluble CD27. Journal of Immunology, 153, 1421-1429.
3. + B cells and helper T cells in immunoglobulin production. European Journal of Immunology, 27, 2073-2079.
4. Agematsu, K., Nagumo, H., Oguchi, Y., Nakazawa, T., Fukushima, K., Yasui, K., Ito, S., Kobata, T., Morimoto, C. & Komiyama, A. (1998) Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood, 91, 173-180.
5. Ahmed, R. & Gray, D. (1996) Immunological memory and protective immunity: understanding their relation. Science, 272, 54-60.
6. Akiba, H., Nakano, H., Nischinaka, S., Shindo, M., Kobata, T., Atsuta, M., Morimoto, C., Ware, C.F., Malinin, N., Wallach, D., Yagita, H. & Okumura, K. (1998) CD27, a member of the Tumor Necrosis Factor Receptor Superfamily, activates NF-kB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAP5, and NF-kB-inducing kinase. Journal of Biological Chemistry, 273, 13353-13358.
7. Allen, R.C., Armitage, R.J., Conley, M.E., Rosenblatt, H., Jenkins, N.A., Copeland, N.G., Bedell, M.A., Edelhoff, S., Disteche, C.M., Simoneaux, D.K., Fanslow, W.C., Belmont, J. & Spriggs, M.K. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science, 259, 990-993.
8. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M., Roberts, R.L., Noelle, R.J., Ledbetter, J.A., Francke, U. & Ochs, H.D. (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell, 72, 291-300.
9. Bahler, D.W. & Levy, R. (1992) Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proceedings of the National Academy of Sciences of the United States of America, 89, 6770-6774.
10. Bahler, D.W., Zelentz, A.D., Chen, T.T. & Levy, R. (1992) Antigen selection in human lymphomagenesis. Cancer Research, 52, (Suppl.), 5547S-5551S.
11. Bowman, M.R., Crimmins, M.A.V., Yetz-Aldape, J., Kriz, R., Kelleher, K. & Herrmann, S. (1994) The cloning of CD70 and its identification as the ligand for CD27. Journal of Immunology, 152, 1756-1761.
12. Brottier, P., Boumsell, L., Gelin, C. & Bernard, A. (1985) T cell activation via CD2 (T,gp50) molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/ T11(1) epitopes. Journal of Immunology, 135, 1624-1631.
13. Camerini, D., Walz, G., Loenen, W.A.M., Borst, J. & Seed, B. (1991) The T-cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. Journal of Immunology, 147, 3165-3169.
14. + T lymphocytes. Journal of Immunology, 152, 1523-1531.
15. Daniel, P.T. & Krammer, P.H. (1994) Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. Journal of Immunology, 152, 5624-5632.
16. Davidson, W.E., Giese, T. & Fredrickson, T.N. (1998) Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. Journal of Experimental Medicine, 187, 1825-1838.
17. Dunn-Walters, D.K., Isaacson, P.G. & Spencer, J. (1995) Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal stone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. Journal of Experimental Medicine, 182, 559-566.
18. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J. & Puck, J.M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81, 935-946.
19. Foy, T.M., Aruffo, A., Bajorath, J., Buhlmann, J.E. & Noelle, J. (1996) Immune regulation by CD40 and its ligand gp39. Annual Review of Immunology, 14, 591-617.
20. Garrone, P., Neidhardt, E-M., Garcia, E., Galibert, L., Van Kooten, C. & Banchereau, J. (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. Journal of Experimental Medicine, 182, 1265-1273.
21. Goodwill, R.G., Alderson, M.R., Smith, C.A., Armitage, R.J., Vandenbos, T., Jerzy, R., Tough, T.W., Schoenborn, M., Davis-Smith, T., Hennen, K., Falk, B., Cosman, D., Baker, E., Sutherland, G.R., Grabstein, K.H., Farrah, T., Giri, J.G. & Beckmann, M.P. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell, 73, 447-456.
22. Gravestein, L.A., Amsen, D., Boes, M., Revilla Calvo, C., Kruisbeek, A.M. & Borst, J. (1998) The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. European Journal of Immunology 28, 2208-2216.
23. Grewal, I.S. & Flavell, R.A. (1998) CD40 and CD154 in cell-mediated immunity, Annual Review of Immunology, 16, 111-135.
24. Gruss, H.J. & Dower, S.K. (1995) Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404.
25. Hintzen, R.Q., Lens, S.M., Beckmann, M.P., Lynch, D., Goodwill, R.G. & van Lier, R.A.W. (1994) Characterization of the human CD27 ligand, a novel member of the TNF gene family. Journal of Immunology, 152, 1762-1773.
26. Hintzen, R.Q., Lens, S.M.A., Lammers, K., Kuiper, H., Beckmann, M.P., Goodwill, R.G. & van Lier, R.A.W. (1995) Engagement of CD27 with its ligand (CD70) provides a second signal for T-cell activation. Journal of Immunology, 154, 2612-2623.
27. Hummel, M., Tamaru, J., Kalvelage, B. & Stein, H. (1994) Mantle cell (previously centrocytic) lymphomas express Vh genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood, 84, 403-407.
28. Johnson, T.A., Rassenti, L.Z. & Kipps, T.J. (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. Journal of Immunology, 158, 235-246.
29. Klas, C., Debatin, K-M., Jonker, R.R. & Krammer, P.H. (1993) Activation interferes with the APO-1 pathway in mature human T cells. International Immunology, 5, 625-630.
30. + peripheral blood B cells expressing the CD27 surface antigen carry somatically mutated V region genes: CD27 as a general marker for somatically mutated (memory) B cells. Journal of Experimental Medicine, 188, 1679-1689.
31. Kobata, T., Agematsu, K., Kameoka, J., Schlossman, S.F. & Morimoto, C. (1994) CD27 is a signal-transducing molecule involved in CD45RA⊣ naive T cell costimulation. Journal of Immunology, 153, 5422-5432.
32. Kobata, T., Jacquot, S., Kozlowski, S., Agematsu, K., Schlossman, S.F. & Morimoto, C. (1995) CD27-CD70 interactions regulate B-cell activation by T cells. Proceedings of the National Academy of Sciences of the United States of America, 92, 11249-11253.
33. Korthäuer, U., Graf, D., Mages, H.W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A.G., Notarangelo, L.D., Levinsky, R.J. & Kroczek, R.A. (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature, 361, 539-541.
34. Kupfer, A., Singer, S.J., Janeway, C.A. & Swain, S.L. (1987) Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells. Proceedings of the National Academy of Sciences of the United States of America, 84, 5888-5892.
35. Lane, P., Traunecker, A., Hubele, S., Unui, S., Lanzavecchia, A. & Gray, D. (1992) Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. European Journal of Immunology, 22, 2573-2578.
36. Lankester, A.C., van Schijndel, G.M.W., Van der Schoot, C.E., van Oers, M.H.J., van Noesel, C.J.M. & van Lier, R.A.W. (1995) Antigen receptor non-responsiveness in chronic lymphocytic leukemia B cells. Blood, 86, 1090-1097.
37. + T cells that induces contact-dependent B cell differentiation (help). Journal of Experimental Medicine, 175, 1091-1101.
38. Lens, S.M.A., de Jong, R., Hooibrink, B., Koopman, G., Pals, S.T., van Oers, M.H.J. & van Lier, R.A.W. (1996a) Phenotype and functions of human B cells expressing CD70 (CD27L). European Journal of Immunology, 26, 2964-2971.
39. Lens, S.M.A., Keehnen, R.M.J., van Oers, M.H.J., van Lier, R.A.W., Pals, S.T. & Koopman, G. (1996b) Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. European Journal of Immunology, 26, 1007-1011.
40. Lens, S.M.A., Tesselaar, K., den Drijver, B.F.A., van Oers, M.H.J. & van Lier, R.A.W. (1996c) A dual role for both CD40L and TNFα in controlling human B-cell death. Journal of Immunology, 156, 507-514.
41. Loenen, W.A.M., Gravestein, L.A., Beumer, S., Melief, C.J.M., Hagemeijer, A. & Borst, J. (1992) Genomic organization and chromosomal localization of the human CD27 gene. Journal of Immunology, 149, 3937-3943.
42. MacLennan, I.C.M. (1994) Germinal centers. Annual Review of Immunology, 12, 117-139.
43. 1 B lymphocyte subset. Journal of Immunology, 148, 3700-3705.
44. Maurer, D., Holter, W., Majdic, O., Fischer, G.F. & Knapp, W. (1990) CD27 expression by a distinct subpopulation of human B lymphocytes. European Journal of Immunology, 20, 2679-2684.
45. Meuer, S.C., Hussey, R.E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K.A., Hodgdon, J.C., Protentis, J.P., Schlossman, S.P. & Reinherz, E.L. (1984) An alternative pathway of T-cell activation: a functional role for the 50kd T11 sheep erythrocyte receptor protein. Cell, 36, 897-906.
46. Michel, F., Merle-B'ral, H., Legac, E., Michel, A., Debre, P. & Bismuth, G. (1993) Defective calcium response in B-chronic lymphocytic leukemia cells: Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. Journal of Immunology, 150, 3624-3633.
47. Pals, S.T., Horst, E., Ossekoppele, G.J., Figdor, C.G., Scheper, R.J. & Meijer, C.J. (1989) Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood, 73, 885-888.
48. Peterson, A. & Seed, B. (1987) Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2). Nature, 329, 842-846.
49. Pollok, K.E., Kim, Y-J., Hurtado, J., Kim, K.K. & Kwon, B.S. (1994) 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. European Journal of Immunology, 24, 367-374.
50. Ranheim, E.A. & Kipps, T.J. (1995) Expression of CD27 and its ligand, CD70, on chronic lymphocytic luekemia B cells. Blood, 12, 3556-3565.
51. Rassenti, L.Z. & Kipps, T.J. (1993) Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 177, 1039-1046.
52. Renshaw, B.R., Fanslow III, W.C., Armitage, R.J., Campbell, K.A., Liggitt, D., Wright, B., Davison, B.L. & Maliszewski, C.R. (1994) Humoral immune responses in CD40 ligand-deficient mice. Journal of Experimental Medicine, 180, 1889-1900.
53. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A.G., Debatin, K.M., Fischer, A. & de Villartay, J.P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349.
54. Rothe, M., Pan, M-G., Henzel, W.J., Ayres, T.M. & Goeddel, D.V. (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins. Cell, 83, 1243-1252.
55. Schattner, E.J., Elkon, K.B., Yoo, D-H., Tumang, J., Krammer, P.H., Crow, M.K. & Friedman, S.M. (1995) CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. Journal of Experimental Medicine, 182, 1557-1565.
56. Stein, H., Schwarting, R., Niedobitek, G. & Dallenbach, F. (1989) Cluster report: CDw70. Leucocyte Typing IV (ed. by W. Knapp et al), p. 446. Oxford University Press.
57. Stuber, E., Neurath, M., Calderhead, D., Fell, H.P. & Strober, W. (1995) Cross-linking of OX40-ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity, 2, 507-521.
58. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T. & Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76. 969-976.
59. Van Kooten, C. & Banchereau. J. (1997) Functions of CD40 on B cells, dendritic cells and other cells. Current Opinion in Immunology, 9, 330-337.
60. van Lier, R.A.W., Borst, J., Vroom, Th.M., Klein, H., van Mourik, P., Zeijlemaker, W.P. & Melief, C.J.M. (1987) Tissue distribution and functional properties of Tp55(CD27), a novel T-cell differentiation antigen. Journal of Immunology, 139, 1589-1596.
61. van Oers, M.H.J., Pals, S.T., Evers, L., Van der Schoot, C.E., Koopman, G., Bonfrer, J.M.G., Hintzen, R.Q., Von dem Borne, A.E.G.Kr. & van Lier, R.A.W. (1991) Expression and release of CD27 in human malignancies. Blood, 82, 3430-3436.
62. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356, 314-316.
63. Wiley, S.R., Goodwin, R.G. & Smith, C.A. (1996) Reverse signalling via CD30 ligand. Journal of Immunology, 157, 3635-3639.
64. Wong, B., Arron, J. & Choi, Y. (1997) T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. Journal of Experimental Medicine, 186, 1939-1944.